Are there any training sessions or webinars on Embase?
Last updated on July 22, 2025
Yes, training sessions and webinars on different aspects of Embase will be made available on a regular basis.
Webinar Recordings
May 15 2025 | Stop Wasting Time — The 5 Literature Search Secrets Every Medical Affairs Professional Needs |
|---|---|
April 9 2025 | Mastering Literature Searches for EU Medical Device Regulation (MDR) Compliance |
October 8 2024 | |
July 10 2024 | Avoid rejection! Top 10 mistakes in medical device literature reviews and how to prevent them |
2023 | |
2022 | How to find information on a disease to explore the need for a new In Vitro Diagnostic (IVD) device |
2022 | How to get started with a CER and how to deal with a gap in the literature for your device |
March 2021 | |
Jan 2021 | Building smart and effective biomedical literature search strategies |
Nov 2020 | How scholarly literature can support Medical Science Liaisons |
June 2020 | |
June 2020 | |
February 2020 | Using machine learning to identify adverse events from scientific literature |
To find out more about this topic, watch the following webinar recordings: | |
To find out more about this topic watch the webinar recording. | |
To find out more about this topic watch the webinar recording. | |
The Medical Device Regulation calls for much stricter clinical data and a continuous process of clinical evaluation. Based on analyses of MDR 2017/745, understanding state of the art (SOTA) is important, as it supports the entire clinical evaluation process. Systematic review of the scientific literature have a lot to offer when it comes to getting the right SOTA information for your device. This webinar discusses:
To find out more about this topic watch the webinar recording or view the slides(Opens in a new tab or window) | |
Biomedical literature plays a key role in the development of effective and safe drugs. To avoid missing important insights it is critical your literature search is comprehensive. Additionally, to be efficient, you would like to avoid retrieving too many non-relevant articles. In this webinar, scientific information experts Dr. Jean Dominique Pierret (Elsevier) and Dr. Caroline Muller (Bioledge) will explain how to quickly and efficiently focus your search on what is essential to you. Wherever you work in drug development, this webinar is relevant for you. Using different databases and real-world examples, they will explain how to work with search operators to retrieve relevant literature. This webinar will allow you to address topics such as:
To find out more about this topic watch the webinar recording or view the slides(Opens in a new tab or window) | |
Medical Affairs specialists facilitate the flow of unbiased information from science to pharma as medical science liaisons. This efficient exchange between the medical community and the pharmaceutical industry is of paramount importance. It helps pharmaceutical companies reduce healthcare costs and better meet consumer expectations. Medical information specialists have become the ‘go-to partner’ within pharma organizations. Comprehensive biomedical literature plays a critical role in synthesizing important literature on on drug safety, pharmacoepidemiology, key opinion leaders (KOLs) and much more.In this webinar, you will learn how you can use Embase to extract and synthesize the most relevant information from a sea of data. Embase is the world’s most comprehensive biomedical research and literature database. Dr. Nadège Krebs discussed how to:
Discover why eight international organizations and regulatory authorities recommend Embase. To find out more about this topic watch the webinar recording or view the slides(Opens in a new tab or window) | |
The new Medical Device Regulation calls for much stricter clinical data and a continuous process of clinical evaluation. Based on analyses of MDR 2017/745, systematic reviews of the scientific literature clearly have a lot to offer for clinical evaluations of medical devices. However, retrieving relevant and high-quality evidence from the ever-increasing volume of Biomedical literature is a challenge. Can Embase® frameworks help synthesize literature evidence from vast amount of available information for a comprehensive Clinical Evaluation Report (CER)? Dr. Iveta Petrova discussed this in a webinar at the MedTech Digital week 2020, where she shared six sections of MDR2017/745 that propose using literature as the source of clinical data and the best practices for formulating a systematic literature search using Embase®. This webinar discusses:
To find out more about this topic watch the webinar recording or view the slides(Opens in a new tab or window) | |
While all types of literature review are becoming reasonably more attractive for students, researchers, practitioners and policy makers the workload involved in all types of evidence synthesis should not be underestimated. Apart from standardization of procedures and methods, many organizations and collaborations started using computers to reduce the workload and save time in processing all types of reviews. Systematic reviews and meta-analyses, scoping reviews, rapid reviews, overviews, and realist reviews are only some members of review family that can benefit from using computer programs. The research, innovations, discussions, and skepticism around and surrounding the automation became so important that some of automation pioneers started International Collaboration for Automation of Systematic Reviews (ICASR) https://icasr.github.io/. The current webinar will also benefit the outcome of ICASR annual meetings. Despite emergence and listing of hundreds of tools in Systematic Review Toolbox (http://systematicreviewtools.com/), these software programs are underused. This webinar will introduce some of these programs alongside the evidence supporting their use and will provide a guide on how to choose the program, when to use them, what are their advantages and disadvantages, and why we should use them. There are automation tools for searching, screening, extracting data, analysis, and report writing. The presentation will also discuss the reasons for underusing problem and its solutions and will justify the fact that automation of evidence synthesis is still an idealist dream and why semi-automation of evidence synthesis is more realistic horizon for in the next decades. To find out more about this topic view the webinar recording | |
Information found in the biomedical literature is a significant source for tracking and reporting adverse drug reactions (ADR). The EMA and FDA have both mandated that market authorization holders maintain active screening of literature for any mentions of ADRs related to their drugs or other medicinal products. Given the increasing amount of literature, manual screening, reviewing and monitoring literature costs more time, money and creates an additional compliance risk. Using the advanced technologies in Artificial intelligence (AI), Machine learning (ML) and Natural language processing (NLP), we have developed models to identify Adverse events (AE) in the literature, which can save considerable time and effort in large-scale analysis and in integrating data from multiple diverse information sources. This webinar discusses:
To find out more about this topic view the webinar recording . | |
Biomedical literature has a critical role in post-market surveillance and vigilance to ensure the safety and effectiveness of drugs and medical devices. In the meantime, data extracted from the literature is being more used in different stages of drug discovery and development to achieve different goals. Understanding the relationship between drug-disease, drug-drug, device-disease and device-device can provide important insights for drug development and re-positioning. In this webinar, Quality Control Scientist Dr. Erin van Buel discussed:
To find out more about this topic view the webinar recording. | |
In this webinar, Elsevier's solution manager Xuanyan Xu demonstrates how Embase is especially suited to help Medical Device manufacturers prepare CER, including:
To find out more about this topic view the webinar recording . | |
In this webinar, Embase product manager Iveta Petrova discusses:
To find out more about this topic view the webinar recording . | |
In this webinar, Julie Glanville will discuss literature searching in Health Economics. To find out more about this topic view the webinar recording. | |
Literature is one of the essential sources to identify high quality ADR reports. Regulatory authorities require companies to monitor major international publications through databases, as well as local, non-English content sources in each of the countries where the drugs are marketed. Currently, the local, non-English content sources is not available in most international literature databases, therefore screening, reviewing and monitoring this type of literature costs extra time, money and creates an additional compliance risk. In this webinar, Embase product manager Iveta Petrova will discuss:
To find out more about this topic view the webinar recording. | |
Databases of peer-reviewed biomedical literature and regulatory documents are crucial sources for pharmacovigilance activities. When monitored properly, they yield drug safety signals that are essential for risk–benefit assessments and adverse event reports. However, both are vast resources that can be challenging to monitor efficiently and accurately, especially if different interfaces are needed to access each database. In 2018, Elsevier is enhancing key solutions for pharmaceutical R&D as part of ongoing efforts to improve the comprehensiveness, efficiency, accuracy and compliance of pharmacovigilance-focused research. By ensuring that all relevant information is captured efficiently, the company is helping drug safety and pharmacovigilance teams deliver considerable improvements in health-critical workflows. This webinar focuses on 2018 enhancements to Embase, PharmaPendium and QUOSA PV, showing how each solution offers dedicated means to boost the efficiency and accuracy of the monitoring of relevant databases, assessment of captured information, and supervision of the workflow. These enhancements include:
The webinar will address these solutions and enhancements in the context of comprehensive support for the goals of pharmacovigilance. To find out more about this topic view the webinar recording . | |
In this webinar, Dr Su Golder NIHR Research Fellow, Health Sciences, at the University of York will discuss:
To find out more about this topic view the webinar recording . | |
The practice of evidence-based medicine (EBM) requires retrieving the knowledge from ever-increasing volume of literature. Librarians have supported EBM by offering information searching skills and various tailored training programs. While users’ needs constantly drive library’s teaching activities, customizable EBM teaching modules have been developed to respond to different needs of library's constituencies, particularly the policy makers within a university’s healthcare system. This involvement creates a new avenue to convey library’s value. To find out more about this topic view the webinar recording . | |
Search methods are part of the research methods in systematic reviews and evidence synthesis. Running a robust search requires following the existing evidence in selection of databases and search filters, addition of limitations, and inclusion of a search methodologist in your team. While a proper evidence-based search protocol could reduce waste and increase value in systematic reviewing, proper reporting should make your search a piece of science. The search methods should be reported in a way that anyone who have access to the databases could repeat the search strategies and search methods (reproducibility) and retrieve the same or very similar search results both in terms of content and numbers (replicability). Following the minimum requirement for reporting the search, the team could produce an evidence-based search method that could be re-used by the readers. The team could also share the search results, as part of their research data, to prevent duplicate efforts for the researchers who want to update the review. To find out more about this topic view the webinar recording . | |
Learn how comparative information from FDA and EMA drug approval documents supports critical drug development decisions. To find out more about this topic view the webinar recording . | |
In this session, Elsevier Solution Marketing Manager Xuanyan Xu and VP of Institutional Offerings Max Dumoulin presented:
To find out more about this topic view the webinar recording . | |
Embase wouldn’t be Embase without Emtree, the life science thesaurus is a hierarchically structured, controlled vocabulary, for Biomedicine and related Life Sciences, providing a consistent description for Embase indexing.
Emtree has been used to index Embase (including Embase Classic) since 1947, and is unrivalled in its coverage of drug and medical terminology. In this webinar, Embase Customer Care Representative Dr. Josephine Zimmermann will walk you through:
To find out more about this topic view the webinar recording . | |
To find out more about this topic view the webinar recording . | |
Join us for this 45-minute webinar that will include in-depth information and demonstrations of how to leverage the comparative data in PharmaPendium to reduce the risk of late-stage failures. With a focus on efficacy, we will discuss how PharmaPendium enables you to:
To find out more about this topic view the webinar recording . | |
Scientific literature is one of the largest source of adverse event reports, making it an essential part of pharmacovigilance. Marketing authorization holders are expected to perform systematic literature searches using reference databases and local journals from countries where the medicinal product has a marketing authorization. The retrieved information needs to be collated, analyzed, and communicated at least once a week. However, several challenges are associated with this process. Large amounts of data from various sources, various regulatory requirements, building and maintaining search strategies increase the complexity of literature searches. In this webinar, Scientific Information Expert Dr. Jean-Dominique Pierret will give a brief overview of regulatory obligations and usefulness of literature in the drug development process. And then he will introduce how he set up literature search for pharmacovigilance: such as selecting the databases, building the strategy with a focus on early detection of safety issue and benefit/risk assessment. Finally, he will give examples of challenges that may occur during literature search for pharmacovigilance. To find out more about this topic view the webinar recording . | |
In this session, Elsevier's product manager, Dr. Iveta Petrova, will demonstrate how Embase can support daily tasks, including:
To find out more about this topic view the webinar recording . | |
Pharmacokinetic information from FDA and EMA regulatory documents informs translational and clinical development decisions and may lead to more successful drug development and regulatory approval strategies. In this webinar, we will discuss how to leverage comparative pharmacokinetic information from FDA and EMA Drug Approval documents to make better-informed decisions on which drugs have the most potential to succeed in clinical development. To find out more about this topic view the webinar recording . | |
In this session, Elsevier's senior product manager Dr. Ivan Krstic demonstrated how Embase is especially suited to help Medical Device manufacturers prepare CER, including:
To find out more about this topic view the webinar recording . | |
The PICO (Patient, Intervention, Comparator/Control, Outcome) process is a technique used in evidence-based practice to frame and answer a clinical question. The PICO framework is also used to develop literature search strategies. In this webinar, Embase solution marketing manager Xuanyan Xu discussed: To find out more about this topic view the webinar recording .
| |
In the context of literature monitoring for adverse reactions to medicinal products (EMA GVP Module VI), a reasonable number of Market Authorization Holders have no ready answer to justify why they use each search formula for each specific product when Audit or Inspection time comes: in fact the search formula, responsible for all the inbound traffic in the Literature Monitoring process is, many times, not validated, or regularly reviewed. How does one create a “good” PV search formula for Literature Monitoring and validate it? By “good” we understand: a formula where you can justify, to an auditor or inspector, why do you use it instead of any other. In this webinar, Elsevier senior product development manager Júlio dos Anjos will discuss the process of (re-)validation of the search formulas used for literature monitoring in the context of EMA's GVP Module VI. This will enable you to create and fine tune the search formula and, when needed, present evidence, to an auditor or inspector, on each search formula fitness for purpose. To find out more about this topic, view the slides or watch the recorded webinar:
| |
Evidence synthesis is the foundation of modern evidence-based medicine. Systematic review, a type of evidence synthesis, requires an exhaustive and comprehensive database search to identify all relevant literature on one or more research question. However, not all evidence synthesis needs a comprehensive literature search. This presentation will give a brief introduction of different types of evidence synthesis and related requirements for literature search.
| |
In this webinar, we discussed:
| |
In this webinar, we discussed how to use Embase for basic biomedical searches. This includes:
To find out more about this topic:
| |
In this webinar, we discussed:
To find out more about this topic, view the slides or watch the recorded webinar:
| |
To meet the clinical need of rapid and accurate diagnosis, new diagnostic tests are continuously developed and several tests are often available for the diagnosis of a particular condition. Finding good evidence regarding the performance of diagnostic tests and interpreting its value for practice is more challenging and less straightforward than for interventions. Most diagnostic studies focus on diagnostic test accuracy. However, estimates of test accuracy often vary markedly between studies. In addition, searching for studies of diagnostic test accuracy is far more difficult because the study designs vary and there is no one term that can be used to filter all diagnostic studies. Systematic reviews of diagnostic test accuracy are carried out to provide an answer to a test accuracy question based on all available evidence, to critically appraise the quality of studies, and account for and explain variations between the results of studies. This talk will cover the question formulation and the interpretation of results of a diagnostic test study, search and selection of literature, quality assessment, meta-analysis, and finally interpretation and summary of findings. To find out more about this topic:
| |
Embase wouldn’t be Embase without Emtree, the life science thesaurus that provides the vocabulary that is used for Embase indexing. In this webinar, Embase Product Manager Yvonne van de Vrede discussed:
To find out more about this topic:
| |
Slides of the webinar can be viewed here. | |
View a video of the archived webinar here. | |
Slides of the webinar can be viewed here. | |
View the slides of the archived webinar here. | |
| |
View a video of the archived webinar here. | |
View a video of the archived webinar here. | |
View a video of the archived webinar here. | |
View the slides or a video of the archived webinar here. | |
A video of the webinar can be viewed here. | |
Slides of the webinar can be viewed here. |
Did we answer your question?
Related answers
Recently viewed answers
Functionality disabled due to your cookie preferences